KAPLAN, O. Et Al. 2024. Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells. EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , vol.72 .

KAPLAN, O., Koc, E., TÜRK, S., Kucukkilinc, T. T., GÖKTAŞ, Z., & ÇELEBİER, M., (2024). Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells. EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , vol.72.

KAPLAN, OZAN Et Al. "Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells," EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , vol.72, 2024

KAPLAN, OZAN Et Al. "Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells." EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , vol.72, 2024

KAPLAN, O. Et Al. (2024) . "Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells." EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , vol.72.

@article{article, author={OZAN KAPLAN Et Al. }, title={Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells}, journal={EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE}, year=2024}